Meglumine (N-Methyl-D-Glucamine)
Therapeutic Category:
Excipient
Forms soluble salt complexes with poorly soluble drugs, enabling injectable use
Primary Use:
Pharmaceutical excipient – used to make APIs water-soluble (e.g., Flunixin Meglumine)
Solubilizing agent – no therapeutic activity; used as a carrier
Target Species:
Pets (dogs and cats)
Status:
Commercial
Monograph:
USP, IP, BP, EP
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.